Search

Your search keyword '"Kolh, P"' showing total 616 results
Start Over Author "Kolh, P"

Refine your results

more »

more »

more »

more »

more »
616 results on '"Kolh, P"'

1. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms

Author

Wanhainen, A., primary, Van Herzeele, I., additional, Bastos Goncalves, F., additional, Bellmunt Montoya, S., additional, Berard, X., additional, Boyle, J.R., additional, D’Oria, M., additional, Prendes, C.F., additional, Karkos, C.D., additional, Kazimierczak, A., additional, Koelemay, M.J.W., additional, Kölbel, T., additional, Mani, K., additional, Melissano, G., additional, Powell, J.T., additional, Trimarchi, S., additional, Tsilimparis, N., additional, Antoniou, G., additional, Björck, M., additional, Coscas, R., additional, Dias, N.V., additional, Kolh, P., additional, Lepidi, S., additional, Mees, B.M.E., additional, Resch, T.A., additional, Ricco, J.B., additional, Tulamo, R., additional, Twine, C.P., additional, Branzan, D., additional, Cheng, S.W.K., additional, Dalman, R.L., additional, Dick, F., additional, Golledge, J., additional, Haulon, S., additional, van Herwaarden, J.A., additional, Ilic, N.S., additional, Jawien, A., additional, Mastracci, T.M., additional, Oderich, G.S., additional, Verzini, F., additional, and Yeung, K.K., additional

Published
2024
Full Text
View/download PDF

2. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia

Author

Conte, Michael S, Bradbury, Andrew W, Kolh, Philippe, White, John V, Dick, Florian, Fitridge, Robert, Mills, Joseph L, Ricco, Jean-Baptiste, Suresh, Kalkunte R, Murad, M Hassan, Aboyans, Victor, Aksoy, Murat, Alexandrescu, Vlad-Adrian, Armstrong, David, Azuma, Nobuyoshi, Belch, Jill, Bergoeing, Michel, Bjorck, Martin, Chakfé, Nabil, Cheng, Stephen, Dawson, Joseph, Debus, Eike S, Dueck, Andrew, Duval, Susan, Eckstein, Hans H, Ferraresi, Roberto, Gambhir, Raghvinder, Gargiulo, Mauro, Geraghty, Patrick, Goode, Steve, Gray, Bruce, Guo, Wei, Gupta, Prem C, Hinchliffe, Robert, Jetty, Prasad, Komori, Kimihiro, Lavery, Lawrence, Liang, Wei, Lookstein, Robert, Menard, Matthew, Misra, Sanjay, Miyata, Tetsuro, Moneta, Greg, Prado, Jose A Munoa, Munoz, Alberto, Paolini, Juan E, Patel, Manesh, Pomposelli, Frank, Powell, Richard, Robless, Peter, Rogers, Lee, Schanzer, Andres, Schneider, Peter, Taylor, Spence, De Ceniga, Melina V, Veller, Martin, Vermassen, Frank, Wang, Jinsong, Wang, Shenming, and GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery, European Society for Vascular Surgery

Subjects
Prevention, Clinical Research, Clinical Trials and Supportive Activities, Cardiovascular, Patient Safety, Good Health and Well Being, Endovascular Procedures, Global Burden of Disease, Humans, International Cooperation, Ischemia, Limb Salvage, Lower Extremity, Peripheral Arterial Disease, Practice Guidelines as Topic, Prevalence, Quality of Life, Severity of Illness Index, Societies, Medical, Specialties, Surgical, Treatment Outcome, Chronic limb-threatening ischemia, Critical limb ischemia, Peripheral artery disease, Diabetes, Foot ulcer, Endovascular intervention, Bypass surgery, Practice guideline, Evidence-based medicine, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Cardiovascular System & Hematology
Abstract

Guideline summaryChronic limb-threatening ischemia (CLTI) is associated with mortality, amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are focused on definition, evaluation, and management of CLTI with the goals of improving evidence-based care and highlighting critical research needs. The term CLTI is preferred over critical limb ischemia, as the latter implies threshold values of impaired perfusion rather than a continuum. CLTI is a clinical syndrome defined by the presence of peripheral artery disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration >2 weeks duration. Venous, traumatic, embolic, and nonatherosclerotic etiologies are excluded. All patients with suspected CLTI should be referred urgently to a vascular specialist. Accurately staging the severity of limb threat is fundamental, and the Society for Vascular Surgery Threatened Limb Classification system, based on grading of Wounds, Ischemia, and foot Infection (WIfI) is endorsed. Objective hemodynamic testing, including toe pressures as the preferred measure, is required to assess CLTI. Evidence-based revascularization (EBR) hinges on three independent axes: Patient risk, Limb severity, and ANatomic complexity (PLAN). Average-risk and high-risk patients are defined by estimated procedural and 2-year all-cause mortality. The GVG proposes a new Global Anatomic Staging System (GLASS), which involves defining a preferred target artery path (TAP) and then estimating limb-based patency (LBP), resulting in three stages of complexity for intervention. The optimal revascularization strategy is also influenced by the availability of autogenous vein for open bypass surgery. Recommendations for EBR are based on best available data, pending level 1 evidence from ongoing trials. Vein bypass may be preferred for average-risk patients with advanced limb threat and high complexity disease, while those with less complex anatomy, intermediate severity limb threat, or high patient risk may be favored for endovascular intervention. All patients with CLTI should be afforded best medical therapy including the use of antithrombotic, lipid-lowering, antihypertensive, and glycemic control agents, as well as counseling on smoking cessation, diet, exercise, and preventive foot care. Following EBR, long-term limb surveillance is advised. The effectiveness of nonrevascularization therapies (eg, spinal stimulation, pneumatic compression, prostanoids, and hyperbaric oxygen) has not been established. Regenerative medicine approaches (eg, cell, gene therapies) for CLTI should be restricted to rigorously conducted randomizsed clinical trials. The GVG promotes standardization of study designs and end points for clinical trials in CLTI. The importance of multidisciplinary teams and centers of excellence for amputation prevention is stressed as a key health system initiative.

Published
2019

3. Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers

Author

Céline Grégoire, Pascale Huynen, Stéphanie Gofflot, Laurence Seidel, Nathalie Maes, Laura Vranken, Sandra Delcour, Michel Moutschen, Marie-Pierre Hayette, Philippe Kolh, Pierrette Melin, and Yves Beguin

Subjects
Medicine, Science
Abstract

Abstract While patient groups at risk for severe COVID-19 infections are now well identified, the risk factors associated with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) transmission and immunization are still poorly understood. In a cohort of staff members of a Belgian tertiary academic hospital tested for SARS-CoV-2 antibodies during the early phase of the pandemic and followed-up after 6 weeks, 3 months and 10 months, we collected personal, occupational and medical data, as well as symptoms based on which we constructed a COVID-19 score. Seroprevalence was higher among participants in contact with patients or with COVID-19 confirmed subjects or, to a lesser extent, among those handling respiratory specimens, as well as among participants reporting an immunodeficiency or a previous or active hematological malignancy, and correlated with several symptoms. In multivariate analysis, variables associated with seropositivity were: contact with COVID-19 patients, immunodeficiency, previous or active hematological malignancy, anosmia, cough, nasal symptoms, myalgia, and fever. At 10 months, participants in contact with patients and those with higher initial COVID-19 scores were more likely to have sustained antibodies, whereas those with solid tumors or taking chronic medications were at higher risk to become seronegative.

Published
2022
Full Text
View/download PDF

6. Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers

Author

Pascale Huynen, Céline Grégoire, Stéphanie Gofflot, Laurence Seidel, Nathalie Maes, Laura Vranken, Sandra Delcour, Michel Moutschen, Marie-Pierre Hayette, Philippe Kolh, Pierrette Melin, and Yves Beguin

Subjects
Medicine, Science
Abstract

Abstract Asymptomatic and pauci-symptomatic cases contribute to underestimating the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Moreover, we have few studies available on the longitudinal follow-up of SARS-CoV-2 antibodies after natural infection. We tested staff members of a Belgian tertiary academic hospital for SARS-CoV-2 IgG, IgM, and IgA antibodies. We analyzed the evolution of IgM and IgG after 6 weeks, and the persistence of IgG after 3 and 10 months. At the first evaluation, 409/3776 (10.8%) participants had a positive SARS-CoV-2 serology. Among initially seropositive participants who completed phases 2 and 3, IgM were still detected after 6 weeks in 53.1% and IgG persisted at 12 weeks in 82.0% (97.5% of those with more than borderline titers). IgG levels were higher and increased over time in symptomatic but were lower and stable in asymptomatic participants. After 10 months, 88.5% of participants had sustained IgG levels (97.0% of those with more than borderline titers).

Published
2022
Full Text
View/download PDF

8. Editor's Choice – Recommendations for Registry Data Collection for Revascularisations of Acute Limb Ischaemia: A Delphi Consensus from the International Consortium of Vascular Registries

Author

Earnshaw, J., Mani, K., Acosta, S., Cochennec, F., Goncalves, F.B., van den, J.C., Diener, H., Rieß, H.C., Gottsäter, A., Hinchliffe, R., Jongkind, V., Koelemay, M., Menyhei, G., Svetlikov, A., Tshomba, Y., Venermo, M., Tulamo, R., Boyle, J.R., de Borst, G.J., Kolh, P., Dick, F., Bertges, D., Eldrup, N., Beck, A.W., Szeberin, Z., Beiles, B., Altreuther, M., Lopez-Espada, C., Aboyans, V., Ricco, J.-B., Espinola-Klein, C., Zeller, T., Schellong, S.M., Hoffmann, U., Twine, C.P., Ambler, G., Thomson, I., Behrendt, Christian-Alexander, Björck, Martin, Schwaneberg, Thea, Debus, Eike S., Cronenwett, Jack, and Sigvant, Birgitta

Published
2019
Full Text
View/download PDF

9. AI-Based Chest CT Analysis for Rapid COVID-19 Diagnosis and Prognosis: A Practical Tool to Flag High-Risk Patients and Lower Healthcare Costs

Author

Giovanni Esposito, Benoit Ernst, Monique Henket, Marie Winandy, Avishek Chatterjee, Simon Van Eyndhoven, Jelle Praet, Dirk Smeets, Paul Meunier, Renaud Louis, Philippe Kolh, and Julien Guiot

Subjects
COVID, SARS-CoV-2, AI-based CT-scan analysis, hospital days reduction, infection reduction, patient flow management, Medicine (General), R5-920
Abstract

Early diagnosis of COVID-19 is required to provide the best treatment to our patients, to prevent the epidemic from spreading in the community, and to reduce costs associated with the aggravation of the disease. We developed a decision tree model to evaluate the impact of using an artificial intelligence-based chest computed tomography (CT) analysis software (icolung, icometrix) to analyze CT scans for the detection and prognosis of COVID-19 cases. The model compared routine practice where patients receiving a chest CT scan were not screened for COVID-19, with a scenario where icolung was introduced to enable COVID-19 diagnosis. The primary outcome was to evaluate the impact of icolung on the transmission of COVID-19 infection, and the secondary outcome was the in-hospital length of stay. Using EUR 20000 as a willingness-to-pay threshold, icolung is cost-effective in reducing the risk of transmission, with a low prevalence of COVID-19 infections. Concerning the hospitalization cost, icolung is cost-effective at a higher value of COVID-19 prevalence and risk of hospitalization. This model provides a framework for the evaluation of AI-based tools for the early detection of COVID-19 cases. It allows for making decisions regarding their implementation in routine practice, considering both costs and effects.

Published
2022
Full Text
View/download PDF

10. Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study

Author

Izidor Mlakar, Simon Lin, Jama Nateqi, Stefanie Gruarin, Lorena Diéguez, Paulina Piairo, Liliana R. Pires, Sara Tement, Ilona Aleksandraviča, Mārcis Leja, Krista Arcimoviča, Valérie Bleret, Jean-François Kaux, Philippe Kolh, Didier Maquet, Jesús Garcia Gómez, Jesus García Mata, Mercedes Salgado, Matej Horvat, Maja Ravnik, Vojko Flis, and Urška Smrke

Subjects
breast cancer survivorship, health-related quality of life, Delphi study, guidance, Medicine
Abstract

(1) Background: The needs of cancer survivors are often not reflected in practice. One of the main barriers of the use of patient-reported outcomes is associated with data collection and the interpretation of patient-reported outcomes (PROs) due to a multitude of instruments and measuring approaches. The aim of the study was to establish an expert consensus on the relevance and key indicators of quality of life in the clinical practice of breast cancer survivors. (2) Methods: Potential indicators of the quality of life of breast cancer survivors were extracted from the established quality of life models, depicting survivors’ perspectives. The specific domains and subdomains of quality of life were evaluated in a two-stage online Delphi process, including an international and multidisciplinary panel of experts. (3) Results: The first round of the Delphi process was completed by 57 and the second by 37 participants. A consensus was reached for the Physical and Psychological domains, and on eleven subdomains of quality of life. The results were further supported by the additional ranking of importance of the subdomains in the second round. (4) Conclusions: The current findings can serve to optimize the use of instruments and address the challenges related to data collection and interpretation as the facilitators of the adaption in routine practice.

Published
2022
Full Text
View/download PDF

11. Editor's Choice – Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)

Author

Naylor, A.R., Ricco, J.-B., de Borst, G.J., Debus, S., de Haro, J., Halliday, A., Hamilton, G., Kakisis, J., Kakkos, S., Lepidi, S., Markus, H.S., McCabe, D.J., Roy, J., Sillesen, H., van den Berg, J.C., Vermassen, F., ESVS Guidelines Committee, Kolh, P., Chakfe, N., Hinchliffe, R.J., Koncar, I., Lindholt, J.S., Vega de Ceniga, M., Verzini, F., ESVS Guideline Reviewers, Archie, J., Bellmunt, S., Chaudhuri, A., Koelemay, M., Lindahl, A.-K., Padberg, F., and Venermo, M.

Published
2018
Full Text
View/download PDF

12. Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines

Author

Boyle, J.R., primary, Tsilimparis, N., additional, Van Herzeele, I., additional, Wanhainen, A., additional, Bastos Gonçalves, F., additional, Bellmunt, S., additional, Berard, X., additional, D’Oria, M., additional, Fernandez, C., additional, Karkos, C., additional, Kazimierczak, A., additional, Koelemay, M., additional, Kölbel, T., additional, Mani, K., additional, Melissano, G., additional, Powell, J., additional, Trimarchi, S., additional, Antoniou, G., additional, Coscas, R., additional, Dias, N., additional, Kolh, P., additional, Lepidi, S., additional, Mees, B., additional, Resch, T., additional, Ricco, J.B., additional, Tulamo, R., additional, Twine, C., additional, and Björck, M., additional

Published
2023
Full Text
View/download PDF

13. Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS)

Author

Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J.J., Lees, T., Lefevre, J.H., Menyhei, G., Oderich, G., ESVS Guidelines Committee, Kolh, P., de Borst, G.J., Chakfe, N., Debus, S., Hinchliffe, R., Kakkos, S., Koncar, I., Sanddal Lindholt, J., Vega de Ceniga, M., Vermassen, F., Verzini, F., Document Reviewers, Geelkerken, B., Gloviczki, P., Huber, T., and Naylor, R.

Published
2017
Full Text
View/download PDF

14. Editor's Choice – Management of Descending Thoracic Aorta Diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)

Author

Riambau, V., Böckler, D., Brunkwall, J., Cao, P., Chiesa, R., Coppi, G., Czerny, M., Fraedrich, G., Haulon, S., Jacobs, M.J., Lachat, M.L., Moll, F.L., Setacci, C., Taylor, P.R., Thompson, M., Trimarchi, S., Verhagen, H.J., Verhoeven, E.L., ESVS Guidelines Committee, Kolh, P., de Borst, G.J., Chakfé, N., Debus, E.S., Hinchliffe, R.J., Kakkos, S., Koncar, I., Lindholt, J.S., Vega de Ceniga, M., Vermassen, F., Verzini, F., Document Reviewers, Black, J.H., III, Busund, R., Björck, M., Dake, M., Dick, F., Eggebrecht, H., Evangelista, A., Grabenwöger, M., Milner, R., Naylor, A.R., Ricco, J.-B., Rousseau, H., and Schmidli, J.

Published
2017
Full Text
View/download PDF

15. Editor's Choice – Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines

Author

Boyle, Jonathan R., primary, Tsilimparis, Nikolaos, additional, Van Herzeele, Isabelle, additional, Wanhainen, Anders, additional, Bastos Gonçalves, F., additional, Bellmunt, S., additional, Berard, X., additional, D’Oria, M., additional, Fernandez, C., additional, Karkos, C., additional, Kazimierczak, A., additional, Koelemay, M., additional, Kölbel, T., additional, Mani, K., additional, Melissano, G., additional, Powell, J., additional, Trimarchi, S., additional, Antoniou, G., additional, Coscas, R., additional, Dias, N., additional, Kolh, P., additional, Lepidi, S., additional, Mees, B., additional, Resch, T., additional, Ricco, J.B., additional, Tulamo, R., additional, Twine, C., additional, and Björck, M., additional

Published
2023
Full Text
View/download PDF

17. Editor's Choice – Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)

Author

Wittens, C., Davies, A.H., Bækgaard, N., Broholm, R., Cavezzi, A., Chastanet, S., de Wolf, M., Eggen, C., Giannoukas, A., Gohel, M., Kakkos, S., Lawson, J., Noppeney, T., Onida, S., Pittaluga, P., Thomis, S., Toonder, I., Vuylsteke, M., ESVS Guidelines Committee, Kolh, P., de Borst, G.J., Chakfé, N., Debus, S., Hinchliffe, R., Koncar, I., Lindholt, J., de Ceniga, M.V., Vermassen, F., Verzini, F., Document Reviewers, De Maeseneer, M.G., Blomgren, L., Hartung, O., Kalodiki, E., Korten, E., Lugli, M., Naylor, R., Nicolini, P., and Rosales, A.

Published
2015
Full Text
View/download PDF

19. 2014 ESC/EACTS GUIDELINES ON MYOCARDIAL REVASCULARIZATION

Author

Stephan Windecker, Philippe Kolh, Fernando Alfonso, Jean-Philippe Collet, Jochen Cremer, Volkmar Falk, Gerasimos Filippatos, Christian Hamm, Stuart J. Head, Peter Jüni, A. Pieter Kappetein, Adnan Kastrati, Juhani Knuuti, Ulf Landmesser, Günther Laufer, Franz-Josef Neumann, Dimitrios J. Richter, Patrick Schauerte, Miguel Sousa Uva, Giulio G. Stefanini, David Paul Taggart, Lucia Torracca, Marco Valgimigli, William Wijns, and Adam Witkowski

Subjects
acute coronary syndromes, bare-metal stents, coronary artery bypass grafting, coronary artery disease, drug-eluting stents, euroscore, guidelines, heart team, myocardial infarction, myocardial ischaemia, myocardial revascularization, medical therapy, percutaneous coronary intervention, recommendation, revascularisation, risk stratification, stents, stable angina, stable coronary artery disease, st-segment elevation myocardial infarction, syntax score, Diseases of the circulatory (Cardiovascular) system, RC666-701
Published
2015
Full Text
View/download PDF

21. European Society for Vascular Surgery Clinical Practice Guideline Development Scheme: An Overview of Evidence Quality Assessment Methods, Evidence to Decision Frameworks, and Reporting Standards in Guideline Development

Author

Antoniou, G.A., primary, Bastos Gonçalves, F., additional, Björck, M., additional, Chakfé, N., additional, Coscas, R., additional, Dias, N.V., additional, Dick, F., additional, Kakkos, S.K., additional, Mees, B.M.E., additional, Resch, T., additional, Trimarchi, S., additional, Tulamo, R., additional, Twine, C.P., additional, Vermassen, F., additional, Wanhainen, A., additional, and Kolh, P., additional

Published
2022
Full Text
View/download PDF

22. Improving model-based cardiac diagnosis with an ECG

Author

Hann, C. E., Chase, J. G., Froissart, C. F., Starfinger, C., Desaive, T., Kok, K., Revie, J., Ghuysen, A., Lambermont, B., Kolh, P., Shaw, G. M., Magjarevic, R., editor, Nagel, J. H., editor, Vander Sloten, Jos, editor, Verdonck, Pascal, editor, Nyssen, Marc, editor, and Haueisen, Jens, editor

Published
2009
Full Text
View/download PDF

23. Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases.

Author

Twine, Christopher P., Kakkos, Stavros K., Aboyans, Victor, Baumgartner, Iris, Behrendt, Christian-Alexander, Bellmunt-Montoya, Sergi, Jilma, Bernd, Nordanstig, Joakim, Saratzis, Athanasios, Reekers, Jim A., Zlatanovic, Petar, Antoniou, George A., de Borst, Gert J., Bastos Gonçalves, Frederico, Chakfé, Nabil, Coscas, Raphael, Dias, Nuno V., Hinchliffe, Robert J., Kolh, Phillipe, and Lindholt, Jes S.

Published
2023
Full Text
View/download PDF

30. Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia' [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1–109>] (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))

Author

Conte M. S., Bradbury A. W., Kolh P., White J. V., Dick F., Fitridge R., Mills J. L., Ricco J. -B., Suresh K. R., Murad M. H., Aboyans V., Aksoy M., Alexandrescu V. -A., Armstrong D., Azuma N., Belch J., Bergoeing M., Bjorck M., Chakfe N., Cheng S., Dawson J., Debus E. S., Dueck A., Duval S., Eckstein H. H., Ferraresi R., Gambhir R., Gargiulo M., Geraghty P., Goode S., Gray B., Guo W., Gupta P. C., Hinchliffe R., Jetty P., Komori K., Lavery L., Liang W., Lookstein R., Menard M., Misra S., Miyata T., Moneta G., Munoa Prado J. A., Munoz A., Paolini J. E., Patel M., Pomposelli F., Powell R., Robless P., Rogers L., Schanzer A., Schneider P., Taylor S., De Ceniga M. V., Veller M., Vermassen F., Wang J., Wang S., Conte M.S., Bradbury A.W., Kolh P., White J.V., Dick F., Fitridge R., Mills J.L., Ricco J.-B., Suresh K.R., Murad M.H., Aboyans V., Aksoy M., Alexandrescu V.-A., Armstrong D., Azuma N., Belch J., Bergoeing M., Bjorck M., Chakfe N., Cheng S., Dawson J., Debus E.S., Dueck A., Duval S., Eckstein H.H., Ferraresi R., Gambhir R., Gargiulo M., Geraghty P., Goode S., Gray B., Guo W., Gupta P.C., Hinchliffe R., Jetty P., Komori K., Lavery L., Liang W., Lookstein R., Menard M., Misra S., Miyata T., Moneta G., Munoa Prado J.A., Munoz A., Paolini J.E., Patel M., Pomposelli F., Powell R., Robless P., Rogers L., Schanzer A., Schneider P., Taylor S., De Ceniga M.V., Veller M., Vermassen F., Wang J., and Wang S.

Subjects
Global Vascular Guidelines, Management, Chronic Limb-Threatening Ischaemia
Abstract

The authors regret that the name of one of the co-author has been incorrectly spelt. Dr. Mauro Garguilo should have been spelt as “Mauro Gargiulo”. The authors would like to apologise for any inconvenience caused.

Published
2020

31. Corrigendum to ‘Editor's Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Vascular Graft and Endograft Infections’ [European Journal of Vascular & Endovascular Surgery 59/3 (2020) 339–384] (European Journal of Vascular & Endovascular Surgery (2020) 59(3) (339–384), (S1078588419325328), (10.1016/j.ejvs.2019.10.016))

Author

Chakfe N., Diener H., Lejay A., Assadian O., Berard X., Caillon J., Fourneau I., Glaudemans A. W. J. M., Koncar I., Lindholt J., Melissano G., Saleem B. R., Senneville E., Slart R. H. J. A., Szeberin Z., Venermo M., Vermassen F., Wyss T. R., ESVS Guidelines Committee, de Borst G. J., Goncalves F. B., Kakkos S. K., Kolh P., Tulamo R., de Ceniga M. V., Document Reviewers, von Allmen R. S., van den Berg J. C., Debus E. S., Koelemay M. J. W., Linares-Palomino J. P., Moneta G. L., Ricco J. -B., Wanhainen A., Chakfe, N., Diener, H., Lejay, A., Assadian, O., Berard, X., Caillon, J., Fourneau, I., Glaudemans, A. W. J. M., Koncar, I., Lindholt, J., Melissano, G., Saleem, B. R., Senneville, E., Slart, R. H. J. A., Szeberin, Z., Venermo, M., Vermassen, F., Wyss, T. R., ESVS Guidelines, Committee, de Borst, G. J., Goncalves, F. B., Kakkos, S. K., Kolh, P., Tulamo, R., de Ceniga, M. V., Document, Reviewer, von Allmen, R. S., van den Berg, J. C., Debus, E. S., Koelemay, M. J. W., Linares-Palomino, J. P., Moneta, G. L., Ricco, J. -B., and Wanhainen, A.

Published
2020

34. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

Author

Kakkos, SK, Gohel, M, Baekgaard, N, Bauersachs, R, Bellmunt-Montoya, S, Black, SA, ten Cate-Hoek, AJ, Elalamy, I, Enzmann, FK, Geroulakos, G, Gottsater, A, Hunt, BJ, Mansilha, A, Nicolaides, AN, Sandset, PM, Stansby, G, de Borst, GJ, Goncalves, FB, Chakfe, N, Hinchliffe, R, Kolh, P, Koncar, I, Lindholt, JS, Tulamo, R, Twine, CP, Vermassen, F, Wanhainen, A, De Maeseneer, MG, Comerota, AJ, Gloviczki, P, Kruip, MJHA, Monreal, M, Prandoni, P, and de Ceniga, MV

Published
2021

35. European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases

Author

Twine, C.P., Kakkos, S.K., Aboyans, V., Baumgartner, I., Behrendt, C.-A., Bellmunt-Montoya, S., Jilma, B., Nordanstig, J., Saratzis, A., Reekers, J.A., Zlatanovic, P., Antoniou, G.A., de Borst, G.J., Bastos Gonçalves, F., Chakfé, N., Coscas, R., Dias, N.V., Hinchliffe, R.J., Kolh, P., Lindholt, J.S., Mees, B.M.E., Resch, T.A., Trimarchi, S., Tulamo, R., Vermassen, F.E.G., Wanhainen, A., Koncar, I., Fitridge, R., Matsagkas, M., and Valgimigli, M.

Published
2023
Full Text
View/download PDF

38. Editor's Choice – European Society for Vascular Surgery Clinical Practice Guideline Development Scheme: An Overview of Evidence Quality Assessment Methods, Evidence to Decision Frameworks, and Reporting Standards in Guideline Development.

Author

Antoniou, George A., Bastos Gonçalves, Frederico, Björck, Martin, Chakfé, Nabil, Coscas, Raphaël, Dias, Nuno V., Dick, Florian, Kakkos, Stavros K., Mees, Barend M.E., Resch, Timothy, Trimarchi, Santi, Tulamo, Riikka, Twine, Chris P., Vermassen, Frank, Wanhainen, Anders, and Kolh, Philippe

Abstract

A structured and transparent approach is instrumental in translating research evidence to health recommendations and evidence informed clinical decisions. The aim was to conduct an overview and analysis of principles and methodologies for health guideline development. A literature review on methodologies, strategies, and fundamental steps in the process of guideline development was performed. The clinical practice guideline development process and methodology adopted by the European Society for Vascular Surgery are also presented. Sophisticated methodologies for health guideline development are being applied increasingly by national and international organisations. Their overarching principle is a systematic, structured, transparent, and iterative process that is aimed at making well informed healthcare choices. Critical steps in guideline development include the assessment of the certainty of the body of evidence; evidence to decision frameworks; and guideline reporting. The goal of strength of evidence assessments is to provide well reasoned judgements about the guideline developers' confidence in study findings, and several evidence hierarchy schemes and evidence rating systems have been described for this purpose. Evidence to decision frameworks help guideline developers and users conceptualise and interpret the construct of the quality of the body of evidence. The most widely used evidence to decision frameworks are those developed by the GRADE Working Group and the WHO-INTEGRATE, and are structured into three distinct components: background; assessment; and conclusions. Health guideline reporting tools are employed to ensure methodological rigour and transparency in guideline development. Such reporting instruments include the AGREE II and RIGHT, with the former being used for guideline development and appraisal, as well as reporting. This guide will help guideline developers/expert panels enhance their methodology, and patients/clinicians/policymakers interpret guideline recommendations and put them in context. This document may be a useful methodological summary for health guideline development by other societies and organisations. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

39. Focused Update on Patients Treated with the Nellix EndoVascular Aneurysm Sealing (EVAS) System from the European Society for Vascular Surgery (ESVS) Abdominal Aortic Aneurysm Clinical Practice Guidelines

Author

Bastos Gonçalves, F., Bellmunt, S., Berard, X., D’Oria, M., Fernandez, C., Karkos, C., Kazimierczak, A., Koelemay, M., Kölbel, T., Mani, K., Melissano, G., Powell, J., Trimarchi, S., Antoniou, G., Coscas, R., Dias, N., Kolh, P., Lepidi, S., Mees, B., Resch, T., Ricco, J.B., Tulamo, R., Twine, C., Björck, M., Boyle, J.R., Tsilimparis, N., Van Herzeele, I., and Wanhainen, A.

Published
2023
Full Text
View/download PDF

41. Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs.

Author

De Maeseneer, Marianne G., Kakkos, Stavros K., Aherne, Thomas, Baekgaard, Niels, Black, Stephen, Blomgren, Lena, Giannoukas, Athanasios, Gohel, Manjit, de Graaf, Rick, Hamel-Desnos, Claudine, Jawien, Arkadiusz, Jaworucka-Kaczorowska, Aleksandra, Lattimer, Christopher R., Mosti, Giovanni, Noppeney, Thomas, van Rijn, Marie Josee, Stansby, Gerry, ESVS Guidelines Committee, Kolh, Philippe, and Bastos Goncalves, Frederico

Published
2022
Full Text
View/download PDF

42. Corrigendum to ‘Management of Chronic Venous Disease: Clinical Practice Guidelines’ [European Journal of Vascular & Endovascular Surgery 49/6 (2015) 678/737]

Author

Wittens, C., primary, Davies, A.H., additional, Bækgaard, N., additional, Broholm, R., additional, Cavezzi, A., additional, Chastanet, S., additional, de Wolf, M., additional, Eggen, C., additional, Giannoukas, A., additional, Gohel, M., additional, Kakkos, S., additional, Lawson, J., additional, Noppeney, T., additional, Onida, S., additional, Pittaluga, P., additional, Thomis, S., additional, Toonder, I., additional, Vuylsteke, M., additional, Kolh, P., additional, de Borst, G.J., additional, Chakfé, N., additional, Debus, S., additional, Hinchliffe, R., additional, Koncar, I., additional, Lindholt, J., additional, Vega de Ceniga, M., additional, Vermassen, F., additional, Verzini, F., additional, De Maeseneer, M.G., additional, Blomgren, L., additional, Hartung, O., additional, Kalodiki, E., additional, Korten, E., additional, Lugli, M., additional, Naylor, R., additional, Nicolini, P., additional, and Rosales, A., additional

Published
2020
Full Text
View/download PDF

43. 2017 ESC update on dual antiplatelet therapy in coronary disease developed in collaboration with the EACTS

Author

Valgimigli A. D. G. D. T. M., Bueno H., Byrne R. A., Collet J. -P., Costa F., Jeppsson A., Juni P., Kastrati A., Kolh P., Mauri L., Montalescot G., Neumann F. -J., Petricevic M., Roffi M., Steg P. G., Windecker S., Zamorano J. L., Levine C. A. G. N., Badimon R. D. D. L., Vranckx P., Agewall S., Andreotti F., Antman E., Barbato E., Bassand J. -P., Bugiardini R., Cikirikcioglu M., Cuisset T., De Bonis M., Delgado V., Fitzsimons D., Gaemperli O., Galie N., Gilard M., Hamm C. W., Ibanez B., Iung B., James S., Knuuti J., Landmesser U., Leclercq C., Lettino M., Lip G., Piepoli M. F., Pierard L., Schwerzmann M., Sechtem U., Simpson I. A., Uva M. S., Stabile E., Storey R. F., Tendera M., Van de Werf F., Verheugt F., Aboyans V., Valgimigli, A. D. G. D. T. M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., Juni, P., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F. -J., Petricevic, M., Roffi, M., Steg, P. G., Windecker, S., Zamorano, J. L., Levine, C. A. G. N., Badimon, R. D. D. L., Vranckx, P., Agewall, S., Andreotti, F., Antman, E., Barbato, E., Bassand, J. -P., Bugiardini, R., Cikirikcioglu, M., Cuisset, T., De Bonis, M., Delgado, V., Fitzsimons, D., Gaemperli, O., Galie, N., Gilard, M., Hamm, C. W., Ibanez, B., Iung, B., James, S., Knuuti, J., Landmesser, U., Leclercq, C., Lettino, M., Lip, G., Piepoli, M. F., Pierard, L., Schwerzmann, M., Sechtem, U., Simpson, I. A., Uva, M. S., Stabile, E., Storey, R. F., Tendera, M., Van de Werf, F., Verheugt, F., and Aboyans, V.

Published
2018

45. Management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)

Author

Naylor, A. R., Ricco, J. -B., de Borst, G. J., Debus, S., de Haro, J., Halliday, A., Hamilton, G., Kakisis, J., Kakkos, S., Lepidi, S., Markus, H. S., Mccabe, D. J., Roy, J., Sillesen, H., van den Berg, J. C., Vermassen, F., Kolh, P., Chakfe, N., Hinchliffe, R. J., Koncar, I., Lindholt, J. S., Vega de Ceniga, M., Verzini, F., Archie, J., Bellmunt, S., Chaudhuri, A., Koelemay, M., Lindahl, A. -K., Padberg, F., Venermo, M., ACS - Amsterdam Cardiovascular Sciences, Surgery, ACS - Atherosclerosis & ischemic syndromes, Naylor, A. R., Ricco, J. -B., de Borst, G. J., Debus, S., de Haro, J., Halliday, A., Hamilton, G., Kakisis, J., Kakkos, S., Lepidi, S., Markus, H. S., Mccabe, D. J., Roy, J., Sillesen, H., van den Berg, J. C., Vermassen, F., Kolh, P., Chakfe, N., Hinchliffe, R. J., Koncar, I., Lindholt, J. S., Vega de Ceniga, M., Verzini, F., Archie, J., Bellmunt, S., Chaudhuri, A., Koelemay, M., Lindahl, A. -K., Padberg, F., and Venermo, M.

Subjects
Bypa, Complications, Medical therapy, Stenting, Transient ischaemic attack, medicine.medical_treatment, Disease, 030204 cardiovascular system & hematology, Imaging, 0302 clinical medicine, Restenosis, Stroke, Endarterectomy, Thrombolysis, 3. Good health, Asymptomatic, Centre for Surgical Research, Cardiology, Screening, Vertebral, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Vertebral artery, Bypass, Thrombolysi, Restenosi, Symptomatic, 03 medical and health sciences, Carotid, Dementia, Patch infection, Surgical techniques, Internal medicine, medicine.artery, Surgery, medicine, business.industry, Surgical technique, Vascular surgery, medicine.disease, business, Complication, 030217 neurology & neurosurgery
Abstract

The European Society of Vascular Surgery (ESVS) has prepared guidelines for treating patients with atherosclerotic carotid and vertebral artery (VA) disease. This does not include non-atherosclerotic conditions such as fibromuscular dysplasia, dissection, arteritis, or trauma. Potential users include vascular surgeons, neurologists, stroke physicians, angiologists, primary care physicians, cardiologists, and interventional radiologists. Guidelines promote standards of care, based on evidence; however, they should not be viewed as the legal standard of care. This document is a “guiding principle” and care given depends on the individual patient (presentation, comorbidities, age) and treatment setting (techniques available, local expertise).

Published
2017

48. Third universal definition of myocardial infarction

Author

Thygesen, K, Alpert, Js, Jaffe, As, Simoons, Ml, Chaitman, Br, White, Hd, the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Biomarker, Subcommittee, Katus, Ha, Apple, Fs, Lindahl, B, Morrow, Da, Ecg, Subcommittee, Clemmensen, Pm, Johanson, P, Hod, H, Imaging, Subcommittee, Underwood, R, Bax, Jj, Bonow, Ro, Pinto, F, Gibbons, Rj, Classification, Subcommittee, Fox, Ka, Atar, D, Newby, Lk, Galvani, M, Hamm, Cw, Intervention, Subcommittee, Uretsky, Bf, Gabriel Steg, P, Wijns, W, Bassand, Jp, Menasché, P, Ravkilde, J, Trials, Registries, Subcommittee, Ohman, Em, Antman, Em, Wallentin, Lc, Armstrong, Pw, Heart Failure Subcommittee, Januzzi, Jl, Nieminen, Ms, Gheorghiade, M, Filippatos, G, Epidemiology, Subcommittee, Luepker, Rv, Fortmann, Sp, Rosamond, Wd, Levy, D, Wood, D, Global Perspective Subcommittee, Smith, Sc, Hu, D, Lopez Sendon JL, Robertson, Rm, Weaver, D, Tendera, M, Bove, Aa, Parkhomenko, An, Vasilieva, Ej, Mendis, S, ESC Committee for Practice Guidelines, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Morais, J, Aguiar, C, Almahmeed, W, Arnar, Do, Barili, F, Bloch, Kd, Bolger, Af, Bøtker, He, Bozkurt, B, Bugiardini, R, Cannon, C, de Lemos, J, Eberli, Fr, Escobar, E, Hlatky, M, James, S, Kern, Kb, Moliterno, Dj, Mueller, C, Neskovic, An, Pieske, Bm, Schulman, Sp, Storey, Rf, Taubert, Ka, Vranckx, P, Wagner, D. R., Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, Botker HE, Bozkurt B, Bugiardini R, Cannon C, de Lemos J, Eberli FR, Escobar E, Hlatky M, James S, Kern KB, Moliterno DJ, Mueller C, Neskovic AN, Pieske BM, Schulman SP, Storey RF, Taubert KA, Vranckx P, Wagner DR., Cardiology, lLindahl B, K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoon, B. R. Chaitman, H. D. White, H. A. Katu, F. S. Apple, B. Lindahl, D. A. Morrow, P. M. Clemmensen, P. Johanson, H. Hod, R. Underwood, J. J. Bax, R. O. Bonow, F. Pinto, R. J. Gibbon, K. A. Fox, D. Atar, L. K. Newby, M. Galvani, C. W. Hamm, B. F. Uretsky, P. Gabriel Steg, W. Wijn, J.-P. Bassand, P. Menasche, J. Ravkilde, E. M. Ohman, E. M. Antman, L. C. Wallentin, P. W. Armstrong, J. L. Januzzi, M. S. Nieminen, M. Gheorghiade, G. Filippato, R. V. Luepker, S. P. Fortmann, W. D. Rosamond, D. Levy, D. Wood, S. C. Smith, D. Hu, J.-L. Lopez-Sendon, R. M. Robertson, D. Weaver, M. Tendera, A. A. Bove, A. N. Parkhomenko, E. J. Vasilieva, S. Mendi, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoe, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirne, A. Torbicki, A. Vahanian, S. Windecker, J. Morai, C. Aguiar, W. Almahmeed, D. O. Arnar, F. Barili, K. D. Bloch, A. F. Bolger, H. E. Botker, B. Bozkurt, R. Bugiardini, C. Cannon, J. de Lemo, F. R. Eberli, E. Escobar, M. Hlatky, S. Jame, K. B. Kern, D. J. Moliterno, C. Mueller, A. N. Neskovic, B. M. Pieske, S. P. Schulman, R. F. Storey, K. A. Taubert, P. Vranckx, D. R. Wagner, Thygesen, K, Alpert, J, Jaffe, A, Simoons, Ml, Chaitman, Br, White, Hd, Katus, Ha, Apple, F, Lindahl, B, Morrow, Da, Clemmensen, Pm, Johanson, P, Hod, H, Underwood, R, Bax, Jj, Bonow, Jj, Pinto, F, Gibbons, Rj, Fox, Ka, Atar, D, Newby, Lk, Galvani, M, Hamm, Cw, Uretsky, Bf, Steg, Pg, Wijns, W, Bassand, Jp, Menasche, P, Ravkilde, J, Ohman, Em, Antman, Em, Wallentin, Lc, Armstrong, Pw, Januzzi, Jl, Nieminen, M, Gheorghiade, M, Filippatos, G, Luepker, Rv, Fortmann, Sp, Rosamond, Wd, Levy, D, Wood, D, Smith, Sc, Hu, D, Lopez-Sendon, Jl, Robertson, Rm, Weaver, D, Tendera, M, Bove, Aa, Parkhomenko, An, Vasilieva, Ej, Mendis, S, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck-Brentano, C, Hasdai, D, Hoes, A, Kirchhof, P, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Morais, J, Aguiar, C, Almahmeed, W, Arnar, Do, Barili, F, Bloch, Kd, Bolger, Af, Botker, He, Bozkurt, B, Bugiardini, R, Cannon, C, de Lemos, J, Eberli, Fr, Escobar, E, Hlatky, M, James, S, Kern, Kb, Moliterno, Dj, Mueller, C, Neskovic, An, Pieske, Bm, Schulman, Sp, Storey, Rf, Taubert, Ka, Vranckx, P, and Wagner, Dr

Subjects
High-sensitivity troponin, Ticagrelor, Chest pain unit, Quality Assurance, Health Care, Epidemiology, medicine.medical_treatment, Myocardial Infarction, Myocardial ischaemia, Global Health, Early invasive strategy, Electrocardiography, Stent, Myocardial Revascularization, Myocardial infarction, Coronary Artery Bypass, Intraoperative Complications, Left bundle branch block, Health Policy, Electrocardiography in myocardial infarction, Cangrelor, Stents, Acute coronary syndrome, Cardiology and Cardiovascular Medicine, Prasugrel, Diagnostic Imaging, medicine.medical_specialty, Public Policy, Risk Assessment, Vorapaxar, Percutaneous Coronary Intervention, Physiology (medical), Terminology as Topic, Humans, Enoxaparin, Bypass surgery, Community and Home Care, Heart Failure, Rhythm monitoring, Aspirin, Unstable angina, Angioplasty, Recommendation, ta3121, medicine.disease, Myocardial infarction diagnosis, Bivalirudin, Biomarkers, Time Factors, Platelet inhibition, Consensus Development Conferences as Topic, Diagnostic Techniques, Cardiovascular, Myocardial Ischemia, Guideline, Diabete, Nitrate, Left ventricular hypertrophy, Coronary artery disease, Rivaroxaban, Recurrence, Apixaban, Clinical Trials as Topic, Graft Occlusion, Vascular, Atherothrombosi, Acute cardiac care, Right bundle branch block, Clopidogrel, Dabigatran, Prosthesis Failure, AHA Scientific Statements, Practice Guidelines as Topic, Cardiology, Biological Markers, Radiology, Critical Care, Glycoprotein IIb/IIIa inhibitor, European Society of Cardiology, Diagnosis, Differential, Anticoagulation, Internal medicine, medicine, Beta-blocker, cardiovascular diseases, Heparin, business.industry, Revascularization, Cardiovascular Surgical Procedures, MYOCARDIAL INFARCTION, Statin, Percutaneous coronary intervention, Arrhythmias, Cardiac, Cardiac Imaging Techniques, Fondaparinux, Heart failure, Non-ST-elevation myocardial infarction, business
Abstract

ACCF : American College of Cardiology Foundation ACS : acute coronary syndrome AHA : American Heart Association CAD : coronary artery disease CABG : coronary artery bypass grafting CKMB : creatine kinase MB isoform cTn : cardiac troponin CT : computed tomography CV : coefficient of variation ECG : electrocardiogram ESC : European Society of Cardiology FDG : fluorodeoxyglucose h : hour(s) HF : heart failure LBBB : left bundle branch block LV : left ventricle LVH : left ventricular hypertrophy MI : myocardial infarction mIBG : meta-iodo-benzylguanidine min : minute(s) MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease) MPS : myocardial perfusion scintigraphy MRI : magnetic resonance imaging mV : millivolt(s) ng/L : nanogram(s) per litre Non-Q MI : non-Q wave myocardial infarction NSTEMI : non-ST-elevation myocardial infarction PCI : percutaneous coronary intervention PET : positron emission tomography pg/mL : pictogram(s) per millilitre Q wave MI : Q wave myocardial infarction RBBB : right bundle branch block sec : second(s) SPECT : single photon emission computed tomography STEMI : ST elevation myocardial infarction ST–T : ST-segment –T wave URL : upper reference limit WHF : World Heart Federation WHO : World Health Organization Myocardial infarction (MI) can be recognised by clinical features, including electrocardiographic (ECG) findings, elevated values of biochemical markers (biomarkers) of myocardial necrosis, and by imaging, or may be defined by pathology. It is a major cause of death and disability worldwide. MI may be the first manifestation of coronary artery disease (CAD) or it may occur, repeatedly, in patients with established disease. Information on MI rates can provide useful information regarding the burden of CAD within and across populations, especially if standardized data are collected in a manner that …

Published
2012

Catalog

Books, media, physical & digital resources
See catalog results